In the TCGA dataset, TET1-MUT was strongly associated with higher tumour mutational burden and neoantigen load, as well as inflammatory patterns, immune features and immune-related gene expression in tumour-infiltrating T lymphocytes. Here, TET1 is linked to neoplasm.